REAGAN KITTS: Open Payments
NPI 1053711689 · RUTLEDGE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 14 payments from 7 companies in 2025. Trend: 2023 $235 · 2024 $292 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $77 |
| Novo Nordisk Inc | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Corcept Therapeutics | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: OTEZLA, CAPLYTA, Ozempic, Korlym, INSPIRE, XIFAXAN, REPATHA, Auvelity.
Industry payments across TN — which companies pay providers there.
